These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27775439)

  • 21. Identification and validation of new autoantibodies for the diagnosis of DCIS and node negative early-stage breast cancers.
    Lacombe J; Mangé A; Jarlier M; Bascoul-Mollevi C; Rouanet P; Lamy PJ; Maudelonde T; Solassol J
    Int J Cancer; 2013 Mar; 132(5):1105-13. PubMed ID: 22886747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological analysis of SEREX-defined medullary breast carcinoma-associated antigens.
    Kostianets O; Shyian M; Sergiy D; Antoniuk S; Gout I; Filonenko V; Kiyamova R
    Cancer Invest; 2012 Aug; 30(7):519-27. PubMed ID: 22712734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries.
    Behrends U; Schneider I; Rössler S; Frauenknecht H; Golbeck A; Lechner B; Eigenstetter G; Zobywalski C; Müller-Weihrich S; Graubner U; Schmid I; Sackerer D; Späth M; Goetz C; Prantl F; Asmuss HP; Bise K; Mautner J
    Int J Cancer; 2003 Aug; 106(2):244-51. PubMed ID: 12800201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies in breast cancer: their use as an aid to early diagnosis.
    Chapman C; Murray A; Chakrabarti J; Thorpe A; Woolston C; Sahin U; Barnes A; Robertson J
    Ann Oncol; 2007 May; 18(5):868-73. PubMed ID: 17347129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancer.
    Seil I; Frei C; Sültmann H; Knauer SK; Engels K; Jäger E; Zatloukal K; Pfreundschuh M; Knuth A; Tseng-Chen Y; Jungbluth AA; Stauber RH; Jäger D
    Int J Cancer; 2007 Jun; 120(12):2635-42. PubMed ID: 17330232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of breast cancer-restricted antigens by antibody screening of SKBR3 cDNA library using a preselected patient's serum.
    Forti S; Scanlan MJ; Invernizzi A; Castiglioni F; Pupa S; Agresti R; Fontanelli R; Morelli D; Old LJ; Pupa SM; Ménard S
    Breast Cancer Res Treat; 2002 Jun; 73(3):245-56. PubMed ID: 12160330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-heat shock protein autoantibody profiling in breast cancer using customized protein microarray.
    Shi L; Gehin T; Chevolot Y; Souteyrand E; Mangé A; Solassol J; Laurenceau E
    Anal Bioanal Chem; 2016 Feb; 408(5):1497-506. PubMed ID: 26715250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer.
    Lee SY; Williamson B; Caballero OL; Chen YT; Scanlan MJ; Ritter G; Jongeneel CV; Simpson AJ; Old LJ
    Cancer Immun; 2004 Nov; 4():13. PubMed ID: 15546177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survey of autoantibody responses against tumor-associated antigens in thyroid cancer.
    Abols A; Ducena K; Zayakin P; Silina K; Kalnina Z; Sadovska L; Tars J; Vilmanis J; Narbuts Z; Eglitis J; Pirags V; Line A
    Cancer Biomark; 2014; 14(5):361-9. PubMed ID: 25171478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The reverse proteomics for identification of tumor antigens.
    Lee SY; Jeoung D
    J Microbiol Biotechnol; 2007 Jun; 17(6):879-90. PubMed ID: 18050904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classifying patients for breast cancer by detection of autoantibodies against a panel of conformation-carrying antigens.
    Evans RL; Pottala JV; Egland KA
    Cancer Prev Res (Phila); 2014 May; 7(5):545-55. PubMed ID: 24641868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer.
    Liu W; De La Torre IG; Gutiérrez-Rivera MC; Wang B; Liu Y; Dai L; Qian W; Zhang JY
    Tumour Biol; 2015 Feb; 36(2):1307-12. PubMed ID: 25355596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential target antigens for immunotherapy identified by serological expression cloning (SEREX).
    Jäger D
    Methods Mol Biol; 2007; 360():319-26. PubMed ID: 17172736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple serological biomarkers for colorectal cancer detection.
    Chan CC; Fan CW; Kuo YB; Chen YH; Chang PY; Chen KT; Hung RP; Chan EC
    Int J Cancer; 2010 Apr; 126(7):1683-90. PubMed ID: 19795454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mapping the high throughput SEREX technology screening for novel tumor antigens.
    Zhou S; Yi T; Zhang B; Huang F; Huang H; Tang J; Zhao X
    Comb Chem High Throughput Screen; 2012 Mar; 15(3):202-15. PubMed ID: 22221053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serological analysis of human renal cell carcinoma.
    Devitt G; Meyer C; Wiedemann N; Eichmüller S; Kopp-Schneider A; Haferkamp A; Hautmann R; Zöller M
    Int J Cancer; 2006 May; 118(9):2210-9. PubMed ID: 16331622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a panel of tumor-associated antigens from breast carcinoma cell lines, solid tumors and testis cDNA libraries displayed on lambda phage.
    Pavoni E; Vaccaro P; Pucci A; Monteriù G; Beghetto E; Barca S; Dupuis ML; De Pasquale Ceratti A; Lugini A; Cianfriglia M; Cortesi E; Felici F; Minenkova O
    BMC Cancer; 2004 Nov; 4():78. PubMed ID: 15541172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of tumor-associated autoantigens with SEREX.
    Türeci O; Usener D; Schneider S; Sahin U
    Methods Mol Med; 2005; 109():137-54. PubMed ID: 15585919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies as potential biomarkers for breast cancer.
    Zhong L; Ge K; Zu JC; Zhao LH; Shen WK; Wang JF; Zhang XG; Gao X; Hu W; Yen Y; Kernstine KH
    Breast Cancer Res; 2008; 10(3):R40. PubMed ID: 18460216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer.
    Li J; Wang LJ; Ying X; Han SX; Bai E; Zhang Y; Zhu Q
    Scand J Immunol; 2012 Mar; 75(3):342-9. PubMed ID: 22010875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.